國家衛生研究院 NHRI:Item 3990099045/4983
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12189/12972 (94%)
造訪人次 : 954762      線上人數 : 688
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/4983


    題名: Pharmacokinetics and physiologically-based pharmacokinetic modeling of nanoparticles
    作者: Yang, SH;Chang, LW;Yang, CS;Lin, P.
    貢獻者: Division of Environmental Health and Occupational Medicine;Center for Nanomedicine Research
    摘要: The worldwide commerce involving nanoparticles will soon reach $1 trillion and already we have more than 600 commercial products containing nanoparticles. Because nanoparticles are invisible and little is known about their toxicities, there has been concern about health effects in humans. As toxicology is a continuum of pharmacokinetics and pharmacodynamics, this is a review of recent advances on pharmacokinetics and physiologically-based pharmacokinetic (PBPK) modeling involving nanoparticles. We provide a synopsis of the state-of-the-science on the absorption, distribution, metabolism, and excretion (ADME) of nanoparticles in mammals, as well as some of the unique applications of pharmacokinetics to nanotechnology. Earlier, the main emphasis of pharmacokinetics of nanoparticles centered around the "control release" of drugs. Thus, drugs encapsulated by lipidic nanoparticles or bound to nano-particles form a controlled-release mechanism. The end results included, among others, enhancement of therapeutic duration and reversion of multidrug resistance. As the science advances in this area, the resulting achievements included: (1) utilizing nanoparticles as delivery vehicle for drugs, drug combinations, or genetic materials; (2) capitalizing on physico-chemical properties and tissue affinity of nanoparticles for medical imaging; (3) potentiating drug effects on immunotoxin and anticancer drugs; and (4) creating "stealth" capability from body's defense system. More recently, the application of biologically-based computer modeling to nanoparticles made it possible not only for inter-species, inter-routes, and inter-dose extrapolations but also for the integration of the modern tumor biology and computational technology for the possible improvement of cancer chemotherapy. Although pharmacokinetics and PBPK modeling of nanoparticles are still in their infancy, impressive innovations have already been demonstrated in their applications to medical sciences. Nanotoxicology is one of the most promising and fertile areas of science given the importance of nanoparticles to the economy of the 21st century, their possible environmental fates, as well as the potential health concerns of these particles.
    日期: 2010-12
    關聯: Journal of Nanoscience and Nanotechnology. 2010 Dec;10(12):8482-8490.
    Link to: http://dx.doi.org/10.1166/jnn.2010.2687
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000283621400084
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=79952108787
    顯示於類別:[林嬪嬪] 期刊論文
    [楊重熙] 期刊論文
    [張惠華(1999-2009)] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PB2010081012.pdf5757KbAdobe PDF874檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋